Possible relationship between certolizumab pegol and arrhythmias: report of two cases
It is still unknown whether there is an association between the use of certolizumab pegol (CZP) in rheumatic patients and the onset of cardiac arrhythmias. We describe the cases of two patients with rheumatoid arthritis (RA) treated with CZP as the first-line biological drug and methotrexate (MTX),...
Saved in:
Main Authors: | R. Talotta (Author), F. Atzeni (Author), A. Batticciotto (Author), D. Ventura (Author), P. Sarzi-Puttini (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2016-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of pyoderma gangrenosum in pregnancy with certolizumab pegol
by: Lindsey J. Wanberg, et al.
Published: (2024) -
Quantitation of certolizumab pegol by validated liquid chromatography methods
by: Clóvis Dervil Appratto Cardoso Júnior, et al.
Published: (2023) -
Active axial spondyloarthritis: potential role of certolizumab pegol
by: Ranatunga S, et al.
Published: (2014) -
Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis
by: A. Spadaro, et al.
Published: (2013) -
Certolizumab pegol treatment for leg ulcers due to rheumatoid vasculitis
by: Maureen Tania Meling, MD, et al.
Published: (2021)